Insider trades
Markus Warmuth, CEO of Monte Rosa Therapeutics GLUE, has filed 0 purchases and 9 sales on the open market. Over the past 12 months that comes to a net sale of $730.9K. The latest trade was on 06/01.
Markus Warmuth
President & CEO
- Company
- Monte Rosa Therapeutics GLUE
- First filing
- 23/01/04
- Trades
- 15 trades
- Buys / sales
- 0 / 9
- 12-month net buying
- −$730.9K
- Last trade
- 06/01
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
GLUE | Open-market sale10b5-1 plan | 06/01 | 06/02 | 5,466 sh2 trades | $19.44avg. | $106,244.82 | −0.9% |
| Open-market sale10b5-1 plan | 05/01 | 05/05 | 5,467 sh | $18.92 | $103,435.64 | −0.9% | |
| Open-market sale | 04/14 | 04/15 | 8,000 sh | $17.64 | $141,120 | −1.3% | |
| Open-market sale10b5-1 plan | 03/02 | 03/04 | 5,466 sh | $17.92 | $97,950.72 | −0.9% | |
GLUE | Open-market sale10b5-1 plan | 01/07 | 01/09 | 5,466 sh3 trades | $23.48avg. | $128,368.81 | −0.9% |
| Open-market sale | 01/05 | 01/05 | 10,135 sh | $15.17 | $153,747.95 | −1.6% |